𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ENDEAVOR II – Long-Term Efficacy and Safety

Publisher
Urban and Vogel
Year
2007
Tongue
German
Weight
318 KB
Volume
32
Category
Article
ISSN
0340-9937

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of deferas
Long-term efficacy and safety of deferasirox
✍ Maria Domenica Cappellini 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Deferasirox is an oral iron chelator, with a long half-life, that can be given once daily, because it provides a 24-hour chelation. Several phase II trials and a pivotal phase III trial have established that, in transfusion-dependent patients with beta-thalassaemia major, deferasirox has a similar e

Long-term botulinum toxin efficacy, safe
Long-term botulinum toxin efficacy, safety, and immunogenicity
✍ Nicte I. Mejia; Kevin Dat Vuong; Joseph Jankovic 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract To determine the long‐term efficacy of botulinum toxin (BTX) treatments, we analyzed longitudinal follow‐up data on 45 patients (32 women; mean age, 68.8 years) currently followed in the Baylor College of Medicine Movement Disorders Clinic, who have received BTX treatments continuously

Long-term safety and efficacy of long-ac
Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients
✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a